Novartis International AG Plans 30% Increase in US Supplies of Fluvirin(R) Influenza Vaccines and Delivery of 40 Million Doses for 2007/2008 Season

Novartis Vaccines, the second largest supplier of influenza vaccines in the US, plans to produce approximately 40 million doses of its Fluvirin® vaccine for distribution in the US during the upcoming 2007/08 influenza season - a 30% increase in supply from Novartis compared to the previous influenza season.